The cytotoxicity of CD38 CAR T to primary AML cells was lower than to primary ALL cells with equivalent levels of CD38 antigen (Fig. 1F and Supplementary Fig. 1C). This evidence concerns the gene CD38 and acute myeloid leukemia.